The New England journal of medicine
-
Randomized Controlled Trial Multicenter Study
Intensive Supportive Care plus Immunosuppression in IgA Nephropathy.
The outcomes of immunosuppressive therapy, when added to supportive care, in patients with IgA nephropathy are uncertain. ⋯ The addition of immunosuppressive therapy to intensive supportive care in patients with high-risk IgA nephropathy did not significantly improve the outcome, and during the 3-year study phase, more adverse effects were observed among the patients who received immunosuppressive therapy, with no change in the rate of decrease in the eGFR. (Funded by the German Federal Ministry of Education and Research; STOP-IgAN ClinicalTrials.gov number, NCT00554502.).